Institutional Ownership Rocket Pharmaceuticals, Inc. (RCKT)
This table provides information about the institutional ownership of Rocket Pharmaceuticals, Inc. (RCKT). We have compiled data on the 243 institutions that hold shares in the stock, with a total of 94.8 Million shares, which have been reported (via 13F filing form) to have a value of $744 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Sterling Capital Management LLC
Charlotte, NC |
Feb 13, 2025 Q4 2024 |
68
shares
|
$533
0.0% of portfolio
|
Q3 2024
New holding
|
|
Cassady Schiller Wealth Management, LLC
Cincinnati, OH |
Feb 10, 2025 Q4 2024 |
62
shares
|
$486
0.0% of portfolio
|
Q4 2024
New holding
|
|
Hughes Financial Services, LLC
Herndon, VA |
May 01, 2025 Q1 2025 |
54
shares
|
$423
0.0% of portfolio
|
Q1 2025
New holding
|
|
Stephens Consulting, LLC
Flint, MI |
Apr 17, 2025 Q1 2025 |
50
shares
|
$392
0.0% of portfolio
|
Q1 2025
New holding
|
|
Lazard Asset Management LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
30
shares
|
$235
0.0% of portfolio
|
Q3 2024
Reduced 61.54%
|
|
First Horizon Advisors, Inc.
|
Apr 28, 2025 Q1 2025 |
24
shares
|
$188
0.0% of portfolio
|
Q3 2023
Reduced 53.85%
|
|
Wealth Trak Capital Management LLC
Virginia Beach, VA |
Feb 12, 2025 Q4 2024 |
10
shares
|
$78
0.0% of portfolio
|
Q4 2024
New holding
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Feb 13, 2025 Q4 2024 |
0
shares
|
$0
0.0% of portfolio
|
Q4 2024
New holding
|
|
Nomura Asset Management CO LTD
Tokyo, M0 |
Feb 12, 2025 Q4 2024 |
0
shares
|
$0
0.0% of portfolio
|
Q4 2024
New holding
|